Simone Bertz Selected Research

Simone Bertz Research Topics

Disease

28	Neoplasms (Cancer) 11/2021 - 01/2009
23	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 08/2010
12	Carcinoma (Carcinomatosis) 01/2021 - 06/2009
3	Lymphatic Metastasis 10/2013 - 04/2011
2	Microsatellite Instability 09/2021 - 01/2019
2	Non-Muscle Invasive Bladder Neoplasms 10/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 04/2019 - 04/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2013 - 01/2012
2	Prostatic Neoplasms (Prostate Cancer) 09/2009 - 04/2009
2	Body Weight (Weight, Body) 09/2009 - 06/2009
2	Margins of Excision 09/2009 - 06/2009
1	Inflammation (Inflammations) 01/2022
1	Multiple Myeloma 01/2022
1	Paraproteinemias (Monoclonal Gammopathy) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Turcot syndrome 11/2021
1	Colonic Neoplasms (Colon Cancer) 11/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2020
1	Pain (Aches) 01/2020
1	Hyperthermia 12/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Polyps 01/2019
1	Carcinoma in Situ 03/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2012
1	Transitional Cell Carcinoma 04/2011
1	Blastomycosis 01/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2009

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2013
5	Phenobarbital (Luminal)FDA Link 11/2021 - 12/2019
4	Cisplatin (Platino)FDA LinkGeneric 04/2014 - 08/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2014
3	Biological ProductsIBA 12/2019 - 01/2012
3	ParaffinIBA 10/2013 - 08/2010
3	Formaldehyde (Formol)FDA Link 10/2013 - 08/2010
2	B7-H1 AntigenIBA 11/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 11/2021 - 04/2014
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
2	Keratins (Keratin)IBA 12/2020 - 04/2009
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 01/2018
2	PlatinumIBA 01/2020 - 12/2019
2	Cadherins (E-Cadherin)IBA 03/2017 - 07/2013
2	AcidsIBA 09/2009 - 06/2009
1	AntibodiesIBA 11/2021
1	LigandsIBA 01/2021
1	NucleotidesIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Calcineurin InhibitorsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Membrane Cofactor ProteinIBA 01/2020
1	Kisspeptin-1 ReceptorsIBA 04/2019
1	A-Form DNA (A-DNA)IBA 04/2019
1	pembrolizumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	atezolizumabIBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Ribonuclease III (RNase III)IBA 01/2019
1	Fibroblast Growth Factor 3IBA 01/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 09/2016
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	Cystine (L-Cystine)IBA 04/2014
1	Trypsin InhibitorsIBA 03/2014
1	AminopeptidasesIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Retinoblastoma ProteinIBA 12/2012
1	Protein Isoforms (Isoforms)IBA 04/2011
1	Transcription Factors (Transcription Factor)IBA 04/2011
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2010
1	Epirubicin (Ellence)FDA LinkGeneric 08/2010
1	Methotrexate (Mexate)FDA LinkGeneric 08/2010
1	protoporphyrin IXIBA 06/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2009

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2009
11	Cystectomy 01/2022 - 12/2012
9	Drug Therapy (Chemotherapy) 01/2021 - 04/2011
5	Adjuvant Chemotherapy 01/2021 - 08/2010
2	Transurethral Resection of Bladder 10/2020 - 12/2019
2	Aftercare (After-Treatment) 01/2020 - 09/2016
2	Radiotherapy 12/2019 - 12/2012
2	Chemoradiotherapy 12/2019 - 09/2016
2	Prostatectomy (Retropubic Prostatectomy) 09/2009 - 06/2009
1	Renal Dialysis (Hemodialysis) 01/2020
1	Immunotherapy 01/2020
1	Combined Modality Therapy 12/2019
1	Lymph Node Excision (Lymph Node Dissection) 12/2019
1	Lasers (Laser) 08/2010
1	Extracorporeal Membrane Oxygenation 01/2009